# Modulation of Central Hypersensitivity in Chronic Musculoskeletal Pain by Intravenous Tropisetron

> **NCT00889499** · PHASE2 · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 30 (actual)

## Conditions studied

- Pain
- Chronic Disease

## Interventions

- **DRUG:** Tropisetron 2 mg
- **DRUG:** Tropisetron 5mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00889499
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2011-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00889499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00889499, "Modulation of Central Hypersensitivity in Chronic Musculoskeletal Pain by Intravenous Tropisetron". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00889499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*